These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35275902)

  • 1. Coronavirus disease 2019 and the liver.
    Esteban JP; Sobotka L; Rockey DC
    Curr Opin Gastroenterol; 2022 May; 38(3):191-199. PubMed ID: 35275902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.
    Alqahtani SA; Barry M; Memish Z; Hashim A; Alfares MA; Alghamdi SA; Al-Hamoudi WK; Al-Judaibi B; Alhazzani W; Al-Tawfiq JA; Abaalkhail F
    Saudi J Gastroenterol; 2021; 27(4):201-207. PubMed ID: 34100388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases.
    Chauhan M; Nzeako I; Li F; Thuluvath PJ
    Ann Hepatol; 2022; 27(4):100702. PubMed ID: 35338012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease.
    Luxenburger H; Thimme R
    Gut; 2023 Sep; 72(9):1783-1794. PubMed ID: 37316169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.
    Song R; Yang C; Li Q; Wang J; Chen J; Sun K; Lv H; Yang Y; Liang J; Ye Q; Gao Y; Li J; Li Y; Yan J; Liu Y; Wang T; Liu C; Zhu P; Wang F; Yin W; Xiang H
    Front Immunol; 2023; 14():1200198. PubMed ID: 37398662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of COVID-19 patients with chronic liver diseases and liver transplants.
    Hu X; Sun L; Guo Z; Wu C; Yu X; Li J
    Ann Hepatol; 2022; 27(1):100653. PubMed ID: 34929350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later.
    Ekpanyapong S; Bunchorntavakul C; Reddy KR
    J Viral Hepat; 2022 Jan; 29(1):4-20. PubMed ID: 34352133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: A systematic review and meta-analysis.
    Luo D; Chen X; Du J; Mei B; Wang A; Kuang F; Fang C; Gan Y; Peng F; Yang X; Dahmen U; Li B; Song S
    Liver Int; 2023 Jan; 43(1):34-48. PubMed ID: 35986903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?
    Soliman HH; Emara MH; Elkadeem M; Abd-Elsalam S
    Infect Disord Drug Targets; 2021; 21(8):e160921189886. PubMed ID: 33397247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
    Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
    Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of COVID-19 on patients with compensated chronic liver diseases.
    Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
    Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease-2019 and Implications on the Liver.
    Campbell PT; Fix OK
    Clin Liver Dis; 2023 Feb; 27(1):27-45. PubMed ID: 36400465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.
    Kulkarni AV; Kumar P; Tevethia HV; Premkumar M; Arab JP; Candia R; Talukdar R; Sharma M; Qi X; Rao PN; Reddy DN
    Aliment Pharmacol Ther; 2020 Aug; 52(4):584-599. PubMed ID: 32638436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and liver disease: mechanistic and clinical perspectives.
    Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
    Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
    Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients.
    Ruether DF; Schaub GM; Duengelhoef PM; Haag F; Brehm TT; Fathi A; Wehmeyer M; Jahnke-Triankowski J; Mayer L; Hoffmann A; Fischer L; Addo MM; Lütgehetmann M; Lohse AW; Schulze Zur Wiesch J; Sterneck M
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):162-172.e9. PubMed ID: 34509643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
    Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
    Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.